Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions, including ...

Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...

The U.S. Food and Drug Administration approved the local company’s 1 milligram dose of epinephrine nasal spray on Wednesday. It’s geared toward patients 4 years and older who weigh at least 33 to 66 ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...

The US Food and Drug Administration (FDA) has approved Neffy, a nasal spray for treating severe allergic reactions in ...

Future Cardiol. 2010;6(4):473-482. Epinephrine administration has been advocated in resuscitation for decades and forms a key component of published guidelines. Its usage is based chiefly on ...

Sophomores at Lynnfield High School presented their Civics Action projects to community members, who were welcomed into the ...

An adrenaline rush is a colloquial expression about the feeling of exhilaration and heightened energy that is brought on by ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...

Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...

Credit: ARS Pharmaceuticals. Neffy 1mg is expected to be available by the end of May 2025. For patients weighing 15kg to less than 30kg, the recommended dose is 1 spray of neffy 1mg. The Food and ...